Ipca Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,459.10
4.5 (0.31%)
BSENSE

Dec 05

BSE+NSE Vol: 2.49 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
2,556.50
2,308.85
2,246.69
2,245.37
2,354.90
2,092.63
2,033.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,556.50
2,308.85
2,246.69
2,245.37
2,354.90
2,092.63
2,033.03
Raw Material Cost
569.87
617.10
660.07
482.44
588.99
545.32
565.05
Purchase of Finished goods
126.83
126.74
86.98
188.29
153.83
118.68
108.57
(Increase) / Decrease In Stocks
84.94
-52.28
-38.76
-2.52
15.74
-20.51
12.27
Employee Cost
537.94
543.17
500.84
485.44
509.84
487.87
466.01
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
692.00
657.70
608.70
628.64
645.02
568.55
559.23
Total Expenditure (Excl Depreciation)
2,011.58
1,892.43
1,817.83
1,782.29
1,913.42
1,699.91
1,711.13
Operating Profit (PBDIT) excl Other Income
544.92
416.42
428.86
463.08
441.48
392.72
321.90
Other Income
27.86
32.66
25.82
20.11
26.26
20.61
18.92
Operating Profit (PBDIT)
572.78
449.08
454.68
483.19
467.74
413.33
340.82
Interest
19.61
18.51
21.51
16.81
22.56
24.05
29.37
Exceptional Items
-58.26
0.00
-205.05
0.00
0.00
0.00
-136.72
Gross Profit (PBDT)
494.91
430.57
228.12
466.38
445.18
389.28
174.73
Depreciation
103.33
100.06
100.12
98.46
100.35
98.89
98.13
Profit Before Tax
391.58
330.51
128.00
367.92
344.83
290.39
76.60
Tax
108.08
96.09
62.22
90.59
99.39
91.41
73.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
283.50
234.42
65.78
277.33
245.44
198.98
2.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
283.50
234.42
65.78
277.33
245.44
198.98
2.91
Share in Profit of Associates
-2.97
-1.53
-1.79
-0.97
0.31
0.16
-1.58
Minority Interest
-2.04
-0.32
-3.83
28.22
16.27
6.90
-58.26
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
282.57
233.21
67.82
248.14
229.48
192.24
59.59
Equity Capital
25.37
25.37
25.37
25.37
25.37
25.37
25.37
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
11.14
9.19
2.67
9.78
9.05
7.58
2.35
Diluted Earnings per share
11.14
9.19
2.67
9.78
9.05
7.58
2.35
Operating Profit Margin (Excl OI)
21.32%
18.04%
19.09%
20.62%
18.75%
18.77%
15.83%
Gross Profit Margin
19.36%
18.65%
10.15%
20.77%
18.9%
18.6%
8.59%
PAT Margin
11.09%
10.15%
2.93%
12.35%
10.42%
9.51%
0.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 10.73% vs 2.77% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 21.17% vs 243.87% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 30.86% vs -2.90% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 5.94% vs -13.95% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Ipca Labs With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,556.50
550.03
2,006.47
364.79%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,556.50
550.03
2,006.47
364.79%
Raw Material Cost
569.87
201.26
368.61
183.15%
Purchase of Finished goods
126.83
0.00
126.83
(Increase) / Decrease In Stocks
84.94
22.10
62.84
284.34%
Employee Cost
537.94
67.72
470.22
694.36%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
692.00
41.04
650.96
1,586.16%
Total Expenditure (Excl Depreciation)
2,011.58
332.12
1,679.46
505.68%
Operating Profit (PBDIT) excl Other Income
544.92
217.91
327.01
150.07%
Other Income
27.86
48.23
-20.37
-42.24%
Operating Profit (PBDIT)
572.78
266.14
306.64
115.22%
Interest
19.61
3.03
16.58
547.19%
Exceptional Items
-58.26
0.00
-58.26
Gross Profit (PBDT)
494.91
263.11
231.80
88.10%
Depreciation
103.33
33.50
69.83
208.45%
Profit Before Tax
391.58
229.60
161.98
70.55%
Tax
108.08
56.17
51.91
92.42%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
283.50
173.43
110.07
63.47%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
283.50
173.43
110.07
63.47%
Share in Profit of Associates
-2.97
0.00
-2.97
Minority Interest
-2.04
0.00
-2.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
282.57
173.43
109.14
62.93%
Equity Capital
25.37
112.32
-86.95
-77.41%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
11.14
3.09
8.05
260.52%
Diluted Earnings per share
11.14
3.09
8.05
260.52%
Operating Profit Margin (Excl OI)
21.32%
39.62%
0.00
-18.30%
Gross Profit Margin
19.36%
47.84%
0.00
-28.48%
PAT Margin
11.09%
31.53%
0.00
-20.44%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,556.50 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 10.73% vs 2.77% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 8.56% vs 15.78% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 282.57 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 21.17% vs 243.87% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 23.13% vs 58.20% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 544.92 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 30.86% vs -2.90% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 23.43% vs 22.44% in Sep 2024

Quarterly - Interest
Interest 19.61 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.94% vs -13.95% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -13.08% vs -48.87% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.32%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024